Written Question·Department of Health and Social Care·UIN 1334

Trastuzumab Deruxtecan

Tabled: 23 July 2024

Answered: 19 August 2024

Named Day

Question

Tonia Antoniazzi

To ask the Secretary of State for Health and Social Care, whether he has made representations to the National Institute for Health and Care Excellence on the availability of Enhertu for patients with HER2-low breast cancer.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be routinely funded by the National Health Service in England independently on the basis of the available evidence of costs and benefits and...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 1334) →